<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent data strongly suggest that "antiphospholipid" autoantibodies are directed against a variety of <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-binding plasma proteins including beta 2GPI, prothrombin, factor Xa, protein C, and protein S </plain></SENT>
<SENT sid="1" pm="."><plain>Further characterization of the spectrum of antibody specificity and affinity in individual patients may explain the varied clinical presentations associated with aPLs </plain></SENT>
<SENT sid="2" pm="."><plain>The next several years hold great promise for a better understanding of the pathophysiology of the aPL syndrome and the precise role of aPLs in the pathogenesis of <z:mp ids='MP_0005048'>thrombosis</z:mp> and recurrent fetal loss </plain></SENT>
</text></document>